In Vitro Susceptibility of Madurella mycetomatis to Posaconazole and Terbinafine
- 1 April 2011
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (4) , 1771-1773
- https://doi.org/10.1128/aac.01045-10
Abstract
Presently, therapy of eumycetoma in Sudan is still based on surgery combined with prolonged ketoconazole therapy. This usually results in a poor clinical outcome. To determine if posaconazole and terbinafine could offer better therapeutic alternatives, the in vitro susceptibilities of 34 Madurella mycetomatis strains were determined. It appeared that posaconazole was highly active against M. mycetomatis but terbinafine was only moderately active. Since posaconazole has an excellent safety profile, it might provide an important alternative in mycetoma therapy.Keywords
This publication has 17 references indexed in Scilit:
- Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2010
- Phenotypic and Molecular Characterization ofMadurella pseudomycetomatissp. nov., a Novel Opportunistic Fungus Possibly Causing Black-Grain MycetomaJournal of Clinical Microbiology, 2010
- Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 AdultsAntimicrobial Agents and Chemotherapy, 2009
- Effects of Age, Gender, and Race/Ethnicity on the Pharmacokinetics of Posaconazole in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2007
- Antifungal Susceptibilities of the Species of the Pseudallescheria boydii ComplexAntimicrobial Agents and Chemotherapy, 2006
- Posaconazole treatment of refractory eumycetoma and chromoblastomycosisRevista do Instituto de Medicina Tropical de São Paulo, 2005
- Genotyping of Madurella mycetomatis by Selective Amplification of Restriction Fragments (Amplified Fragment Length Polymorphism) and Subtype Correlation with Geographical Origin and Lesion SizeJournal of Clinical Microbiology, 2005
- Clinical efficacy and safety of oral terbinafine in fungal mycetomaInternational Journal of Dermatology, 2004
- In Vitro Susceptibilities of Madurella mycetomatis to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2 H - Tetrazolium Hydroxide (XTT) AssayAntimicrobial Agents and Chemotherapy, 2004
- Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against Candida albicans , Candida glabrata , and Candida kruseiAntimicrobial Agents and Chemotherapy, 2003